Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The glycosylation of the circulating immunoglobulin-gamma (IgG) antibody molecules changes in rheumatoid arthritis. The extent of the changes correlates with the disease severity and reverses in remission. We demonstrate here that the alteration in glycosylation associated with rheumatoid arthritis can create a new mode for the interaction of IgG with complement through binding to the collagenous lectin mannose-binding protein (MBP). Rheumatoid arthritis is associated with a marked increases in IgG glycoforms that lack galactose (referred to as G0 glycoforms) in the Fc region of the molecule and that terminate in N-acetyl glucosamine (GlcNAc). We show, using nuclear magnetic resonance (NMR) and X-ray data, that these terminal GlcNAc residues become accessible for MBP binding. We further demonstrate that multiple presentation of IgG-G0 glycoforms to MBP results in activation of the complement. This suggests that a contribution to the chronic inflammation of the synovial membrane could arise from the localization of the IgG-G0 glycoforms in the affected joint and from resulting activation of complement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Modified Spin-Echo Method for Measuring Nuclear Relaxation Times
Meiboom, S., & Gill, D. (1958) · Review of Scientific Instruments · doi:10.1063/1.1716296 · Cited by 6,022
The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain
Porter, R. R. (1959) · Biochemical Journal · doi:10.1042/bj0730119 · Cited by 2,308
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Self-citationStructure of a C-type mannose-binding protein complexed with an oligosaccharide
Weis, W. I., Drickamer, K., & Hendrickson, W. A. (1992) · Nature · doi:10.1038/360127a0 · Cited by 885
The binding site for C1q on IgG
Duncan, A. R., & Winter, G. (1988) · Nature · doi:10.1038/332738a0 · Cited by 569
Drickamer, K., Dordal, M. S., & Reynolds, L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62698-0 · Cited by 429
Serum lectin with known structure activates complement through the classical pathway.
Ikeda, K., Sannoh, T., Kawasaki, N., Kawasaki, T., & Yamashina, I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47587-4 · Cited by 424
Trimeric structure of a C-type mannose-binding protein
Weis, W. I., & Drickamer, K. (1994) · Structure · doi:10.1016/s0969-2126(94)00124-3 · Cited by 307
Research works printed but not linked: 2
- Chang, S.-C. Altered Glycosylation in Immunoglobulin G and Its Fragments in Rheumatoid Arthritis. thesis, Oxford (1993).
- Parekh, R.B. A Study of the Structure and Biosynthesis of N-linked Oligosaccharides and of their Involvement in Certain Diseases. thesis, Oxford Univ.(1987).
Cited by
Items 501–600 of 844
Pongrácz, T., Biewenga, M., Stoelinga, A., Bladergroen, M. R., Nicolardi, S., Trouw, L. A., Wuhrer, M., de Haan, N., & van Hoek, B. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05173-z · Cited by 15
Estrogen-Driven Changes in Immunoglobulin G Fc Glycosylation
Lagattuta, K. A., & Nigrovic, P. A. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_11 · Cited by 16
Pernin, V., Bec, N., Beyze, A., Bourgeois, A., Szwarc, I., Champion, C., Chauvin, A., René, C., Mourad, G., Merville, P., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16904 · Cited by 15
Tinker, tailor, soldier, cell: the role of C-type lectins in the defense and promotion of disease
Arnold, J. N., & Mitchell, D. A. (2022) · Protein & Cell · doi:10.1093/procel/pwac012 · Cited by 15
“In light of the IgG-G0 glycan interaction with CTLs such as MBL which have the potential to activate complement (Malhotra et al., 1995), it is interesting to consider the potential role of CTLs in the therapeutic response to these antibodies where glyco-engineering approaches can be employed to generate the optimal gl…”
BackgroundInfluentialChen, S., Chen, L., Gu, H., Mehta, A. S., Li, J., Romano, P. B., Horn, D., Hooper, D. C., Bazemore‐Walker, C. R., & Block, T. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044422 · Cited by 15
“For example, serum levels of G0 IgG are unusually high in rheumatoid arthritis, Myositis Syndromes [23], Lambert-Eaton myasthenic syndrome [24], Crohn’s disease, and other inflammatory diseases and are closely correlated with disease severity [25–27].”
BackgroundSialic Acid Residues Are Essential for the Anaphylactic Activity of Murine IgG1 Antibodies
Silva, S. D. R., Casabuono, A. C., Jacysyn, J. F., Favoretto, B. C., Fernandes, I., de Macedo, M. S., Couto, A. S., & Faquim-Mauro, E. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8308 · Cited by 15
NMR Detection of Semi-Specific Antibody Interactions in Serum Environments
Yanaka, S., Yamazaki, T., Yogo, R., Noda, M., Uchiyama, S., Yagi, H., & Kato, K. (2017) · Molecules · doi:10.3390/molecules22101619 · Cited by 15
“Furthermore, it has been proposed that serum immunoglobulin (Ig) can be reactive with endogenous lectins through carbohydrate moieties attached to the Fc region under pathological conditions [2].”
BackgroundKanoh, Y., Ohara, T., Tadano, T., Kanoh, M., & Akahoshi, T. (2008) · PubMed · Cited by 15
Chung, S.-W., Joo, H., Jang, K., Lee, H.-J., Lee, S., & Kim, B. (2005) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2005.09.007 · Cited by 15
Bowman, K. A., Wiggins, C. D., DeRiso, E. A., Paul, S. B., Strle, K., Branda, J. A., Steere, A. C., Lauffenburger, D. A., & Alter, G. (2024) · iScience · doi:10.1016/j.isci.2024.108804 · Cited by 14
Agostino, M., Sandrin, M. S., Thompson, P. E., Ramsland, P. A., & Yuriev, E. (2010) · Biopolymers · doi:10.1002/bip.21427 · Cited by 14
Emerging immunotherapies for autoimmune kidney disease
Foster, M. H., & Ord, J. R. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1555569 · Cited by 14
Ebrahimiyan, H., Mostafaei, S., Aslani, S., Faezi, S. T., Farhadi, E., Jamshidi, A., & Mahmoudi, M. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00758-0 · Cited by 14
Sweet Rules: Linking Glycosylation to Antibody Function
Nimmerjahn, F., & Werner, A. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_12 · Cited by 15
Diversity of complement activation in different thyroid diseases
Zhao, C., Yu, Y., Liu, J., Lu, G., Li, T., Gao, Y., Zhang, J., & Guo, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108636 · Cited by 14
Smarz-Widelska, I., Chojęta, D., & Kozioł, M. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095301 · Cited by 14
Krishna, S., Jung, S. T., & Lee, E. Y. (2024) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2024.2342969 · Cited by 14
“For example, agalactosylation in IgG allowed the binding of mannose-binding lectin onto core GlcNAc sugars, which activated the complement system [61].”
Kuroda, Y., Nakata, M., Nose, M., Kojima, N., & Mizuochi, T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02974-x · Cited by 14
The pivotal nature of sugars in normal physiology and disease
Alavi, A., & Axford, J. S. (2006) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-005-0247-4 · Cited by 14
A case of renal sarcoidosis with complement activation via the lectin pathway
Hagiwara, S., Ohi, H., Eishi, Y., Kodama, F., Tashiro, K., Makita, Y., Suzuki, Y., Maeda, K., Fukui, M., Horikoshi, S., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.11.020 · Cited by 14
Molecular and Cellular Pathways of Immunoglobulin G Activity In Vivo
Nimmerjahn, F. (2014) · ISRN Immunology · doi:10.1155/2014/524081 · Cited by 14
“Apart from this so called classical pathway of complement activation via C1q through IgG and IgMmolecules, there is data suggesting that certain IgG variants which we will discuss later, may also be able to activate a nonclassical pathway of complement activation [9–11].”
BackgroundSerum galactosyltransferase isoform changes in rheumatoid arthritis.
Alavi, A., Axford, J. S., & Pool, A. J. (2004) · PubMed · Cited by 14
Significance and Molecular Basis for IgG Glycosylation Changes in Rheumatoid Arthritis
Rademacher, T. W., Jones, R., & Williams, P. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1885-3_20 · Cited by 14
Mirshafiey, Chitsaz, Attar, Mehrabian, & Razavi (2000) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2000.00779.x · Cited by 14
Engineering Glycosylation in Animal Cells
Bailey, J. E., Prati, E. G. P., Jean-Mairet, J., Sburlati, A. R., & Umaña, P. (1998) · Springer eBooks · doi:10.1007/0-306-46860-3_2 · Cited by 14
Importance and Monitoring of Therapeutic Immunoglobulin G Glycosylation
Mimura, Y., Saldova, R., Mimura‐Kimura, Y., Rudd, P. M., & Jefferis, R. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_15 · Cited by 14
Self-citationSerological and cellular inflammatory signatures in end‐stage kidney disease and latent tuberculosis
McLean, M. R., Wragg, K. M., López, E., Kiazyk, S. A. K., Ball, T. B., Bueti, J., Kent, S. J., Juno, J. A., & Chung, A. W. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1355 · Cited by 13
Meng, X., Wang, F., Gao, X., Wang, B., Xu, X., Wang, Y., Wang, W., & Zeng, Q. (2022) · The EPMA Journal · doi:10.1007/s13167-022-00311-3 · Cited by 13
Sun, W., Jian, X., Zhang, J., Meng, X., Wang, H., Zheng, D., Wu, L., & Wang, Y. (2024) · Molecules · doi:10.3390/molecules29061281 · Cited by 13
“It is suggested that IgG lacking terminal galactoses exhibits pro-inflammatory effects by activating complement through the alternative pathway and by binding to mannose-binding lectin (MBL) to activate the lectin pathway [33,34].”
BackgroundKristiansen, M., Frisch, M., MADSEN, H. O., Garred, P., & Jacobsen, S. (2013) · Rheumatology International · doi:10.1007/s00296-013-2904-z · Cited by 13
Lectin pathway factors in patients suffering from juvenile idiopathic arthritis
Kasperkiewicz, K., Eppa, Ł., Świerzko, A. S., Bartłomiejczyk, M. A., Żuber, Z. M., Siniewicz‐Luzeńczyk, K., Mężyk, E., Matsushita, M., Bąk‐Romaniszyn, L., Zeman, K., et al. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.31 · Cited by 13
Sweet turning bitter: Carbohydrate sensing of complement in host defence and disease
Hevey, R., Pouw, R. B., Harris, C. L., & Ricklin, D. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15307 · Cited by 13
“Aside from pathogens, MBL can also bind via its CRD to aberrantly glycosylated IgG and IgA molecules (Malhotra et al., 1995; Roos et al., 2001).”
BackgroundGlycosylation of Therapeutic IgGs
Mimura, Y., Jefferis, R., Mimura‐Kimura, Y., Abrahams, J. L., & Rudd, P. M. (2009) · Wiley eBooks · doi:10.1002/9780470485408.ch3 · Cited by 14
Self-citationMirshafiey, A., Mehrabian, F., Razavi, A., Shidfar, M. R., & Namaki, S. (2000) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(00)00075-6 · Cited by 13
The sweets standing at the borderline between allo‐ and xenotransplantation
Jang, K., Kim, Y., Adhya, M., Park, H., & Kim, B. (2013) · Xenotransplantation · doi:10.1111/xen.12030 · Cited by 13
Jalasutram, V. (2011) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb11.924 · Cited by 13
The effect of blood sampling and preanalytical processing on human N-glycome
Dědová, T., Grunow, D., Kappert, K., Flach, D., Tauber, R., & Blanchard, V. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200507 · Cited by 13
Cedzyński, M., Kilpatrick, D. C., & Świerzko, A. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810420-0.00004-3 · Cited by 13
Structural heterogeneity of glycans in IgA molecules: Implications for IgA nephropathy
Mestecky, J. F., & Tomana, M. (1997) · Nephrology · doi:10.1111/j.1440-1797.1997.tb00280.x · Cited by 13
Mannose-binding lectin deficiency associated with neutrophil chemotactic unresponsiveness to C5a☆☆☆
TEN, R. M., Carmona, E. M., Babovic‐Vuksanovic, D., & Katzmann, J. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70387-8 · Cited by 13
Molecular Biology and Immunology for Clinicians 25: Defense Collagens
Sigal, L. H. (2003) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000081261.38158.44 · Cited by 13
Deep learning enhanced the diagnostic merit of serum glycome for multiple cancers
Zhang, H., Liu, S., Wang, Y., Huang, H., Sun, L., Yuan, Y., Cheng, L., Liu, X., & Ning, K. (2023) · iScience · doi:10.1016/j.isci.2023.108715 · Cited by 12
IgG Glycans as a Biomarker of Biological Age
Vilaj, M. Ć., Gudelj, I., Trbojević‐Akmačić, I., Lauc, G., & Pezer, M. (2019) · Healthy ageing and longevity · doi:10.1007/978-3-030-24970-0_7 · Cited by 12
Gupta, B., Raghav, S. K., & Das, H. R. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.01.009 · Cited by 12
Structural Basis of Pattern Recognition by Innate Immune Molecules
McGreal, E. P. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0901-5_10 · Cited by 12
Yau, L., Liu, J., Jiang, M., Bai, G., Wang, J., & Jiang, Z. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.05.027 · Cited by 12
Rhodes, J. M., Campbell, B. J., & Yu, L. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92002-6 · Cited by 12
MHC-Restricted T Cell Responses against Posttranslationally Modified Peptide Antigens
Kastrup, I. B., Andersen, M. H., Elliott, T. J., & Haurum, J. S. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)78006-6 · Cited by 12
Balen, B., Milošević, J., & Krsnik‐Rasol, M. (2002) · Food Technology and Biotechnology · Cited by 12
The Mannose-Binding Lectin (MBL) Route for Activation of Complement
Kojima, M., Presanis, J. S., & Sim, R. B. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0065-0_15 · Cited by 12
Self-citationKim, S.-M., Chang, K.-H., & Oh, D. J. (2018) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-018-0109-8 · Cited by 11
N-Glycosylation of Antibodies: Biological Effects During Infections and Therapeutic Applications
Castañeda‐Casimiro, J., Vallejo‐Castillo, L., Peregrino, E. S., Hernández-Solís, A., Vázquez-Flores, L., Chacón‐Salinas, R., Wong‐Baeza, I., & Serafín‐López, J. (2025) · Antibodies · doi:10.3390/antib14040093 · Cited by 12
“Agalactosy-lated N-glycans bind to Man-binding protein (MBP) and induce complement activation through this pathway, which may induce a chronic inflammatory profile in people who have agalactosylated antibodies [63].”
Altered Fc galactosylation in IgG4is a potential serum marker for chronic lung disease
Heyder, T., Wiklundh, E., Eklund, A., James, A. J., Dahlén, S., Grünewald, J., Zubarev, R. A., & Lundström, S. L. (2018) · ERJ Open Research · doi:10.1183/23120541.00033-2018 · Cited by 11
Ronco, P. M., Vivarelli, M., Ayalon, R., & Dêbiec, H. (2021) · Springer eBooks · doi:10.1007/978-3-642-27843-3_94-1 · Cited by 11
Fukami, Y., Koike, H., Iijima, M., Mouri, N., Nishi, R., & Katsuno, M. (2022) · Muscle & Nerve · doi:10.1002/mus.27636 · Cited by 11
Targeting mechanisms at sites of complement activation for imaging and therapy
Holers, V. M. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.04.005 · Cited by 11
Zhang, C., Zhu, J., Li, S.-L., Wang, H., & Zhu, Q. (2014) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2014.975247 · Cited by 11
“The possibly favorable role of MBL on RA is under debate that it has been demonstrated physiologically MBL can interact with agalactosylated IgG, an altered profile of IgG common in RA patients, and mediate complement activity in vitro, thus may induce synovial inflammation (21).”
BackgroundEffects of Galactosylation in Immunoglobulin G from All-Atom Molecular Dynamics Simulations
Fortunato, M., & Colina, C. M. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp504243e · Cited by 12
A novel pathogenesis of inflammatory bowel disease from the perspective of glyco-immunology
Shinzaki, S., Iijima, H., Fujii, H., Kamada, Y., Naka, T., Takehara, T., & Miyoshi, E. (2017) · The Journal of Biochemistry · doi:10.1093/jb/mvx010 · Cited by 11
Low prevalence of rheumatoid arthritis among patients with pre-existing type 2 diabetes mellitus
Tentolouris, A., Thanopoulou, A. C., Tentolouris, N., Eleftheriadou, I., Voulgari, C., Andrianakos, A., & Sfikakis, P. P. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.09.14 · Cited by 11
“It is known that changes due to modification in the Fc region of immunoglobulins such as glycosylation influences the effector function of IgG mediated by its receptor and activates the classical pathway of the complement system (34-38).”
BackgroundCarbohydrate moiety of immunoglobulins in health and pathology.
Krotkiewski, H. (1999) · Acta Biochimica Polonica · doi:10.18388/abp.1999_4167 · Cited by 11
ESAT-6 and CFP-10 reactive IgG in patients with tuberculosis inhibits intracellular bacteria
Miles, J., Lu, P., Bai, S., Aguillón-Durán, G. P., Rodríguez-Herrera, J. E., Gunn, B. M., Restrepo, B. I., & Lu, L. L. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116653 · Cited by 10
“105,106 Thus, different glycans on IgG can have divergent effects.”
The Biological Basis and Analyses of N-Glycan Microheterogeneity
Adams, T. M., Zhao, P., Seenivasan, S. H., & Wells, L. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101491 · Cited by 11
“…of agalactosylated IgG glycans demonstrate that in the absence of Gal, the underlying glycan is liberated from glycan–protein interactions and adopts a more flexible conformation that allows the terminal GlcNAcs to be recognized by the complement-activating lectin mannose-binding protein (141).”
Higel, F., Seidl, A., Demelbauer, U. M., Sörgel, F., & Frieß, W. (2014) · mAbs · doi:10.4161/mabs.29263 · Cited by 10
Dumić, J., Cvetko, A., Abramović, I., Goreta, S. Š., Perović, A., Bratičević, M. N., Kifer, D., Sinčić, N., Gornik, O., & Žarak, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.855682 · Cited by 10
“The observed increase in monogalyctosylated N-glycans after five dives (W5 compared to W1) is related to suppressed complement activation by IgG, which consequently decreases its inflammatory potential (51, 52).”
BackgroundZhang, R., Guo, L., Sha, J., Chang, S., Zhao, J., Wang, K., Wang, J., Gu, J., Liu, J., & Ren, S. (2023) · Phenomics · doi:10.1007/s43657-023-00096-z · Cited by 10
“To date, the associations between aberrant glycosylation and many autoimmune diseases, including systemic lupus erythematosus (SLE) (Vučković et al. 2015), rheumatoid arthritis (RA) (Malhotra et al. 1995), and inflammatory bowel disease (IBD) (Clerc et al. 2018), has been widely reported.”
BackgroundSerum immunoglobulin and the threshold of Fc receptor-mediated immune activation
Bauer-Smith, H., Sudol, A. S. L., Beers, S. A., & Crispin, M. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130448 · Cited by 10
“The proposal that terminal GlcNAc can activate complement by mannose binding protein [295] has been questioned by the observation that the efficacy of antibodies with deferential galactose levels is unaffected in mice by the knockout of the mannose binding protein gene [296].”
Lambert, M., Brodovitch, A., Mège, J., Bertin, D., & Bardin, N. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103585 · Cited by 10
Zhou, X., Kailemia, M. J., Sun, Y. H., Shuai, Z., Yang, G., Dhaliwal, S., Cristoferi, L., Leung, P. S. C., Invernizzi, P., Bowlus, C. L., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102503 · Cited by 10
Neuraminidase Inhibitor Zanamivir Ameliorates Collagen-Induced Arthritis
Sehnert, B., Mietz, J., Rzepka, R., Buchholz, S., Maul‐Pavicic, A., Schaffer, S., Nimmerjahn, F., & Voll, R. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031428 · Cited by 10
Gaikwad, H. K., Li, Y., Wang, G., Li, R., Dai, S., Rester, C., Kedl, R. M., Saba, L. M., Banda, N. K., Scheinman, R. I., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c02794 · Cited by 10
Trinder, P. K. E., Hickling, T. P., Sim, R. B., Brackertz, D., Loos, M., & Maeurer, M. J. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01185.x · Cited by 10
Self-citationDissecting the Antibody Constant Region Protective Immune Parameters in HIV Infection
Chung, A. W., & Alter, G. (2014) · Future Virology · doi:10.2217/fvl.14.19 · Cited by 10
Antibody glycosylation as a potential biomarker for chronic inflammatory autoimmune diseases
Knopf, J., Biermann, M. H. C., Munoz, L. E., & i, M. H. (2016) · Global Medical Genetics · doi:10.3934/genet.2016.4.280 · Cited by 11
“Rheumatoid arthritis Total serum IgG/IgG1 Decreased galactosylation [34,36-38] Rheumatoid arthritis Total serum IgG Decreased sialylation [35,38] Rheumatoid arthritis Total serum IgG Increased Fc core fucosylation [38]”
BackgroundFully galactosyl-fucosyl-bisected IgG1 reduces anti-HBV efficacy and liver histological improvement
Ho, C.-H., Chen, S., Tsai, H., Wu, I., & Chang, T. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2018.12.021 · Cited by 10
Szekrényes, Á., Szigeti, M., Dvorakova, V., Járvás, G., & Guttman, A. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.115728 · Cited by 10
Yu, X., & Wang, W. (2021) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0016 · Cited by 10
“A study on RA demonstrated that the agalactosylated IgG glycan due to its exposure of the mannose-rich core glycan structure acquires the capacity to bind to mannose-binding lectin, providing an explanation for this enhanced proin-flammatory activity in vivo (Malhotra et al., 1995).”
Galactosylation of serum IgG and autoantibodies in murine models of autoimmune haemolytic anaemia
Barker, R. N., Young, R. D., Leader, K. A., & Elson, C. J. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.01001.x · Cited by 10
Impact of Fc Glycosylation on Monoclonal Antibody Effector Functions and Degradation by Proteases
Raju, T. S. (2009) · Springer eBooks · doi:10.1007/978-0-387-76643-0_15 · Cited by 10
Saevarsdóttir, S., Ding, B., Steinsson, K., Gröndal, G., Valdimarsson, H., Alfredsson, L. S., Klareskog, L., & Padyukov, L. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3321 · Cited by 9
“MBL can bind to antibodies, including agalactosylated IgG (which is increased in RA patients), IgA, certain IgM isoforms, and immune complexes [8,33-35].”
Exploiting natural anti-carbohydrate antibodies for therapeutic purposes
Bello‐Gil, D., & Máñez, R. (2015) · Biochemistry (Moscow) · doi:10.1134/s0006297915070044 · Cited by 9
“these terminal sugar residues exposes the high mannose core heptasaccharide, which can now be recognized by mannose-binding lectin (MBL) in vitro [71].”
BackgroundFan, W. (2011) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb11.2313 · Cited by 9
“Glycation changes may induce increased MBL autoreactivity (Malhotra et al., 1995), which may explain why diabetic patients are more susceptible to the unfavorable effects of high MBL levels.”
BackgroundErcan, A. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2005-7 · Cited by 9
“In this space, N-glycans modify the outer surface of the IgG Fc domain and thus affect the binding affinity of the IgG Fc fragment toward the Fc gamma receptors (Lund et al., 1990; Malhotra et al., 1995; Anthony et al., 2011; Ahmed et al., 2014; Subedi et al., 2014; Nandakumar et al., 2018).”
BackgroundInfluentialRussell, A. C., & Wang, W. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_17 · Cited by 9
Minor structural changes, major functional impacts: posttranslational modifications and drug targets
Kim, H. J. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01409-y · Cited by 9
Serum IgG Glycan Hallmarks of Systemic Lupus Erythematosus
Pan, H., Wang, J., Liang, Y. Q., Wang, C., Tian, R., Ye, H., Zhang, X., Wu, Y., Shao, M., Zhang, R., et al. (2023) · Engineering · doi:10.1016/j.eng.2023.01.006 · Cited by 9
Chang, T., Tsai, H.-W., & Ho, C. (2018) · Cancers · doi:10.3390/cancers10110460 · Cited by 9
Best-first search guided multistage mass spectrometry-based glycan identification
Wang, Y., Bu, D., Huang, C., Wang, H., Zhou, J., Dong, J., Pan, W., Zhang, J., Zhang, Q., Li, Y., et al. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz056 · Cited by 9
Segarra-Medrano, A., Muijsemberg, A., Wimbury, D. H., Martín, M., Escalante, E. J., González, J., Campàs, L. C., García-Carrasco, A., Martínez, C., & Barratt, J. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa356 · Cited by 9
Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions
Dall’Olio, F., & Malagolini, N. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_10 · Cited by 9
Agalactosyl IgG and materno-fetal transmission of autoimmune neonatal lupus
Pilkington, C., Taylor, P. V., Silverman, E. D., Isenberg, D. A., Costello, A. M. D. L., & Rook, G. A. W. (1996) · Rheumatology International · doi:10.1007/bf01409979 · Cited by 9
“This could conceivably involve binding of mannanbinding protein or lectin-like membrane receptors to the terminal N-acetylglucosamine residues on the agalactosyl oligosaccharides [22].”
BackgroundNew Insights into Rheumatoid Arthritis Associated Glycosylation Changes
Alavi, A., Pool, A. J., & Axford, J. S. (2005) · Advances in experimental medicine and biology · doi:10.1007/0-387-25515-x_23 · Cited by 9
“For example, agalactosylation of IgG can trigger the inappropriate activation of complement ( 21 ), is an important component of rheumatoid factor-IgG complexes in RA (22, 23) and has been shown to be pathogenic in animal models of this disease (8, 11).”
BackgroundAgalactosyl IgG and mannose-binding proteins: Biochemical nicety or pathophysiological paradigm?
Ezekowitz, R. A. B. (1995) · Nature Medicine · doi:10.1038/nm0395-207 · Cited by 9
Modulation of FcγR and human complement activation by IgG3-core oligosaccharide interactions
Jefferis, R., Lund, J., & Goodall, M. D. (1996) · Immunology Letters · doi:10.1016/s0165-2478(96)02656-9 · Cited by 9
Glycoproteins and Antibodies: Solution NMR Studies
Kato, K., & Yamaguchi, Y. (2011) · Wiley eBooks · doi:10.1002/9780470034590.emrstm1233 · Cited by 9
Immune response to chemically modified proteome
Bhat, S., Mary, S., Banarjee, R., Giri, A. P., & Kulkarni, M. J. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300068 · Cited by 8
Glycosylation des autoanticorps au cours des maladies auto-immunes
Goulabchand, R., Batteux, F., & Guilpain, P. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2013.09.005 · Cited by 8
Origin of Galactose‐Deficient Immunoglobulin G in Gingival Crevicular Fluid in Periodontitis
Komiyama, Y., Kafkova, L. R., Barasch, A., Shah, G. R., Grbic, J. T., Novák, Z., Komiyama, K., Novák, J., Mestecky, J. F., & Moldoveanu, Z. (2014) · Journal of Periodontology · doi:10.1902/jop.2014.140212 · Cited by 8
Raised levels of agalactosyl IgG in childhood tuberculosis
Pilkington, C., Başaran, M. M., Barlan, I. B., Costello, A. M. D. L., & Rook, G. A. W. (1996) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(96)90124-8 · Cited by 8
NMR assignments of the N-glycans of the Fc fragment of mouse immunoglobulin G2b glycoprotein
Yanaka, S., Yamaguchi, Y., Takizawa, T., Miyanoiri, Y., Yogo, R., Shimada, I., & Kato, K. (2021) · Biomolecular NMR Assignments · doi:10.1007/s12104-020-10004-5 · Cited by 8
Metadata
- Authors
- Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B.
- Affiliations
- University of Oxford (GB)
- Venue
- Nature Medicine
- Published
- 1995-03
- Volume
- 1
- Issue
- 3
- Pages
- 237-243
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2053863608
- Cited by
- 786
- References
- 33
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 21 · 2023: 17 · 2022: 34 · 2021: 29 · 2020: 25 · 2019: 32 · 2018: 35 · 2017: 34 · 2016: 32 · 2015: 27 · 2014: 36 · 2013: 36 · 2012: 29
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- rheumatoid arthritis, IgG glycosylation, mannose-binding protein, complement activation, Fc fragment, N-acetylglucosamine, synovitis, chronic inflammation
- MeSH terms
- Arthritis, Rheumatoid, Carbohydrate Sequence, Carrier Proteins, Complement Activation, Computer Simulation, Glycosylation, Humans, Immunoglobulin G, Immunoglobulin Fc Fragments, Models, Molecular, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Synovial Fluid, Mannose-Binding Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.